Iris Moll
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Developmental Biology and Gene Regulation 3
- Melanoma and MAPK Pathways 2
- RNA regulation and disease 2
-
- Immune Cell Function and Interaction 2
- Co-authors
- Antje Sucker (10 shared papers)Dirk Schadendorf (10 shared papers)Susanne Horn (2 shared papers)Rajiv Kumar (2 shared papers)Eduardo Nagore (2 shared papers)Kari Hemminki (2 shared papers)Christine Fischer (1 shared paper)P. Sivaramakrishna Rachakonda (1 shared paper)
- Journals
- PLoS ONE (3 papers)EMBO Molecular Medicine (3 papers)Clinical Cancer Research (2 papers)Nature Communications (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Iris Moll
30 papers receiving 2.7k citations
Iris Moll's Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 833
- Cancer Research 416
- Aging 48
- Immunology 513
- Physiology 470
Countries citing papers authored by Iris Moll
This map shows the geographic impact of Iris Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Moll more than expected).
Fields of papers citing papers by Iris Moll
This network shows the impact of papers produced by Iris Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Moll. The network helps show where Iris Moll may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Moll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TERT Promoter Mutations in Familial and Sporadic Melanoma Hit paper breakdown → | 2013 | 1331 |
| 2 | 2017 | 242 | |
| 3 | 2009 | 156 | |
| 4 | 2014 | 135 | |
| 5 | 2006 | 95 | |
| 6 | 2008 | 81 | |
| 7 | 2013 | 80 | |
| 8 | 2013 | 75 | |
| 9 | 2015 | 60 | |
| 10 | 2022 | 50 | |
| 11 | 2017 | 45 | |
| 12 | 2011 | 44 | |
| 13 | 2010 | 40 | |
| 14 | 2018 | 33 | |
| 15 | 2023 | 30 | |
| 16 | 2018 | 28 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 20 | |
| 19 | 2022 | 18 | |
| 20 | 2015 | 18 |
About Iris Moll
Iris Moll is a scholar working on Molecular Biology, Immunology, Oncology, Neurology and Dermatology, having authored 31 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (3 papers), Developmental Biology and Gene Regulation (3 papers), Barrier Structure and Function Studies (2 papers), Melanoma and MAPK Pathways (2 papers), RNA regulation and disease (2 papers), Immune Cell Function and Interaction (2 papers), Cerebrovascular and genetic disorders (2 papers) and Vascular Malformations Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (833 citations), Cancer Research (416 citations), Aging (48 citations), Immunology (513 citations) and Physiology (470 citations). Iris Moll has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Antje Sucker, Dirk Schadendorf, Susanne Horn, Rajiv Kumar, Eduardo Nagore, Kari Hemminki, Christine Fischer, P. Sivaramakrishna Rachakonda, Adina Figl and Andreas Gast. Their work appears in journals such as PLoS ONE, EMBO Molecular Medicine, Clinical Cancer Research, Nature Communications and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.